Headline
The latest stories from AHA Today.
Johnson & Johnson announced its request that the Food and Drug Administration amend the current emergency use authorization for the J&J COVID-19 vaccine to include a booster dose.
AstraZeneca said it has requested an emergency use authorization from the Food and Drug Administration for its long-acting antibody combination for the prevention of symptomatic COVID-19.
The Food and Drug Administration authorized the emergency use of a new over-the-counter COVID-19 antigen test. Unlike most antigen tests for at-home use, the new test does not require serial testing, FDA said.
COVID-19 vaccinations may have helped prevent an estimated 265,000 COVID-19 infections, 107,000 hospitalizations and 39,000 deaths among Medicare beneficiaries between January and May 2021, according to a study released by the Department of Health and Human Services’ Office of the Assistant…
The upcoming Accelerating Health Equity Conference is seeking participants who can help lead discussions via breakout sessions or poster presentations.
The Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee Oct. 1 announced that it will meet later this month for a pair of significant discussions on COVID-19 vaccines.
The Federal Emergency Management Agency last week released guidance intended to streamline the application process for hospital generator projects under its Hazard Mitigation Assistance programs.
The Health Resources and Services Administration Oct. 5 will host the second in a series of webinar sessions on how to apply for a portion of $25.5 billion in COVID-19 relief funds.
El Camino Health in Mountain View, Calif., will host a free virtual symposium Oct. 7 on maternal mental health.
The AHA is accepting applications through Oct. 15 for its 2022 Quest for Quality Prize.